menu
    • menu

    Company profile for Aurion Biotech

    NEW Drugs in Dev: 3
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aurion BiotechUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    701 Pike Street, Suite 2225, Seattle, WA 98101, United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aurionbiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aurion-biotech/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/aurionbiotech

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurion Biotech to Present at Eye Bank and Ophthalmology Meetings
    Aurion Biotech to Present at Eye Bank and Ophthalmology Meetings

    28 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260528195872/en/Aurion-Biotech-to-Highlight-Momentum-Across-Upcoming-Eye-Bank-and-Ophthalmology-Meetings-in-June

    BUSINESSWIRE
    28 May 2026
    Share Share
    Aurion Biotech to Present Corneal Cell Therapy Data at ASGCT 2026
    Aurion Biotech to Present Corneal Cell Therapy Data at ASGCT 2026

    06 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260506579210/en/Aurion-Biotech-to-Give-Oral-Presentation-on-Regenerative-Cell-Therapy-for-Corneal-Endothelial-Disease-at-ASGCT-2026

    BUSINESSWIRE
    06 May 2026
    Share Share
    Aurion Biotech doses first patients in phase 3 ASTRA study
    Aurion Biotech doses first patients in phase 3 ASTRA study

    08 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260408682814/en/Aurion-Biotech-Doses-First-Patients-in-ASTRA-Phase-3-Study-Evaluating-AURN001-in-Patients-with-Corneal-Edema-Secondary-to-Corneal-Endothelial-Dysfunction

    BUSINESSWIRE
    08 Apr 2026
    Share Share
    Aurion Bio Hits All Endpoints In AURN001 Ph 1/2 CLARA Trial
    Aurion Bio Hits All Endpoints In AURN001 Ph 1/2 CLARA Trial

    18 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251018009011/en/Aurion-Biotech-Achieves-All-Primary-Secondary-and-Exploratory-Endpoints-in-AURN001-Phase-12-CLARA-Trial-at-12-Months

    BUSINESSWIRE
    18 Oct 2025
    Share Share
    Aurion Bio Promotes Torres To Chief Manufacturing Officer
    Aurion Bio Promotes Torres To Chief Manufacturing Officer

    30 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250930926770/en/Aurion-Biotech-Expands-Leadership-Team-Promoting-Andrew-Torres-Ph.D.-to-Chief-Manufacturing-Officer-and-Sterling-Chung-to-Chief-Regulatory-Quality-Officer

    BUSINESSWIRE
    30 Sep 2025
    Share Share
    Aurion Biotech names Edward J. Holland Chief Medical Officer
    Aurion Biotech names Edward J. Holland Chief Medical Officer

    23 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250423074583/en/Aurion-Biotech-Appoints-Edward-J.-Holland-M.D.-as-Chief-Medical-Officer-and-Eris-P.-Jordan-O.D.-as-Chief-Development-Officer

    BUSINESSWIRE
    23 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search